HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Investment predicted for natural personal-care industry

This article was originally published in The Rose Sheet

Executive Summary

According to research and consulting firm Organic Monitor, investment activity in natural and organic personal-care companies is expected to rise in 2010. "Improving economic conditions and easing of capital restrictions are making investors target this high-growth sector once again," the firm says in recently published Strategic Insight research report. Major deals - such as Shiseido's $1.5 bil. purchase of Bare Escentuals in January - suggest firms are increasingly open to acquisitions and mergers. Private companies in Europe especially will be targeted in major deals in 2010 because many leading U.S.-based firms in the industry have already been acquired, Organic Monitor says. Report also found that the most successful natural personal-care companies are those that, once acquired, receive investment but continue to operate as separate entities

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016743

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel